Harrow HROW
NASDAQ HROW
$37.65 -0.20 (-0.53%)
As of: Sep 9, 2026 · 2:26 PM EDT

Harrow (HROW) Total Non-Current Liabilities (2014 - 2024)

Harrow (HROW) posted Total Non-Current Liabilities of $291.2 million for Q3 2024, up 18.5% on a QoQ basis from $245.7 million in Q2 2024, and up 40.04% year-over-year from $208.0 million in Q4 2023.

Analysis

Harrow (HROW) Total Non-Current Liabilities (2014 - 2024) Analysis & Trends

Harrow has reported Total Non-Current Liabilities for 10 years, with the latest figure at $291.2 million in Q3 2024.

  • On a quarterly basis, Total Non-Current Liabilities rose 40.04% year-over-year to $291.2 million in Q3 2024; TTM through Sep 2024 was $291.2 million, a 40.04% increase from a year earlier, with the FY2023 full-year figure at $239.0 million, changed N/A from the prior year.
  • Total Non-Current Liabilities was $291.2 million for Q3 2024 at Harrow, up from $245.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $291.2 million in Q3 2024, with the low at $27.6 million in Q1 2021.
  • Average Total Non-Current Liabilities over 4 years is $147.1 million, with a median of $196.7 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities retreated 11.21% in 2021, then jumped 40.04% in 2024.
  • Over 4 years, Total Non-Current Liabilities stood at $29.8 million in 2020, then slipped by 7.59% to $27.6 million in 2021, then surged by 766.65% to $239.0 million in 2023, then gained by 21.82% to $291.2 million in 2024.
  • The last three Total Non-Current Liabilities figures came in at $291.2 million (Q3 2024), $245.7 million (Q2 2024), and $232.6 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 105.99 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn 106.45 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 16.16 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 48.34 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 100.86 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn 32.04 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn - 1.53 Bn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 1.40 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 607.80 Mn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 291.21 Mn
Jun 30, 2024 245.74 Mn
Mar 31, 2024 232.62 Mn
Dec 31, 2023 239.04 Mn
Sep 30, 2023 207.95 Mn
Jun 30, 2023 199.66 Mn
Mar 31, 2023 193.70 Mn
Mar 31, 2021 27.58 Mn
Dec 31, 2020 29.85 Mn
Sep 30, 2020 33.74 Mn
Jun 30, 2020 33.26 Mn
Mar 31, 2020 31.07 Mn
Dec 31, 2019 30.87 Mn
Sep 30, 2019 30.17 Mn
Jun 30, 2019 29.36 Mn
Mar 31, 2019 28.68 Mn
Dec 31, 2018 23.90 Mn
Sep 30, 2018 23.04 Mn
Jun 30, 2018 21.80 Mn
Mar 31, 2018 20.32 Mn